Epstein–Barr virus and multiple sclerosis

SS Soldan, PM Lieberman - Nature Reviews Microbiology, 2023 - nature.com
Epstein–Barr virus (EBV) is a ubiquitous human lymphotropic herpesvirus with a well-
established causal role in several cancers. Recent studies have provided compelling …

[HTML][HTML] Epstein-Barr virus and systemic autoimmune diseases

G Houen, NH Trier - Frontiers in immunology, 2021 - frontiersin.org
Epstein-Barr Virus (EBV) is an extremely successful human herpes virus, which infects
essentially all human beings at some time during their life span. EBV infection and the …

[HTML][HTML] Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation

JE Gold, RA Okyay, WE Licht, DJ Hurley - Pathogens, 2021 - mdpi.com
Pathogens | Free Full-Text | Investigation of Long COVID Prevalence and Its Relationship to
Epstein-Barr Virus Reactivation Next Article in Journal Epidemiological Aspects of Maternal …

The global landscape of EBV-associated tumors

C Shannon-Lowe, A Rickinson - Frontiers in oncology, 2019 - frontiersin.org
Epstein-Barr virus (EBV), a gamma-1 herpesvirus, is carried as a life-long asymptomatic
infection by the great majority of individuals in all human populations. Yet this seemingly …

NK-/T-cell lymphomas

H Wang, B Fu, RP Gale, Y Liang - Leukemia, 2021 - nature.com
Natural killer/T-cell lymphoma (NKTL) is a sub-type of Epstein–Barr virus (EBV)-related non-
Hodgkin lymphomas common in Asia and Latin America but rare elsewhere. Its …

EBV-associated diseases: Current therapeutics and emerging technologies

S Chakravorty, B Afzali, M Kazemian - Frontiers in Immunology, 2022 - frontiersin.org
EBV is a prevalent virus, infecting> 90% of the world's population. This is an oncogenic virus
that causes~ 200,000 cancer-related deaths annually. It is, in addition, a significant …

An introduction to virus infections and human cancer

JT Schiller, DR Lowy - Viruses and human cancer: from basic science to …, 2021 - Springer
Abstract Approximately, 1.4 million virus-induced cancers occur annually, representing
roughly 10% of the worldwide cancer burden, with the majority (> 85%) occurring in the …

Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy

SE Ahmadi, M Soleymani, F Shahriyary… - Cancer Gene …, 2023 - nature.com
Gene editing-based therapeutic strategies grant the power to override cell machinery and
alter faulty genes contributing to disease development like cancer. Nowadays, the principal …

Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma

W Li, X Duan, X Chen, M Zhan, H Peng… - Frontiers in …, 2023 - frontiersin.org
Epstein–Barr virus (EBV) was the first tumor virus in humans. Nasopharyngeal carcinoma
(NPC) accounts for approximately 60% of the 200,000 new tumor cases caused by EBV …

Epstein–Barr virus as a potentiator of autoimmune diseases

WH Robinson, S Younis, ZZ Love, L Steinman… - Nature Reviews …, 2024 - nature.com
Abstract The Epstein–Barr virus (EBV) is epidemiologically associated with development of
autoimmune diseases, including systemic lupus erythematosus, Sjögren syndrome …